TABLE 1.
Susceptibility of the Mmas porin mutants to antibiotics.
| Strains | AMI | APR | AZI | CIP | CLA | ERY | TET | KAN | CEF | IMI | TIG | LIN |
| Mmas CIP108297 | 16–32 | 2 | 1–2 | 32–64 | 0.25 | 8–16 | 32 | 8 | 64 | 32 | 2–4 | 16 |
| MmasΔmmpA | 32 | 2–4 | 1–2 | 128 | 0.5 | 8 | 8 | 8 | 64 | 64–128 | 4 | 16 |
| MmasΔmmpB | 16–64 | 4 | 2 | 32–64 | 0.5 | 16 | 16 | 8 | 64 | 32 | 4 | 16 |
| MmasΔmmpA/pOMK-mmpA | 64 | 2 | 2 | 32 | 1 | 32 | 8 | nd | 64 | 64 | 4 | 16 |
| MmasΔmmpA/pOMK-mmpAB | 32 | 4 | 4 | 32 | 1 | 16 | 16 | nd | 64 | 64 | 4 | 16 |
| MmasΔmmpB/pOMK-mmpB | 32 | 4 | 2 | 32 | 0.25 | 8 | 8 | nd | 64 | 32 | 2–4 | 16 |
| MmasΔmmpB/pOMK-mmpAB | 32 | 4 | 2 | 32 | 0.5 | 8 | 8 | nd | 64 | 32 | 4 | 16 |
MIC were determined in Mueller-Hinton II broth and MIC values are in μg/ml.AMI, amikacin; APR, apramycin; AZI, azithromycin; CEF, cefoxitin; CIP, ciprofloxacin; CLA, clarithromycin; ERY, erythromycin; IMI, imipenem; KAN, kanamycin; LIN, linezolid; TET, tetracycline; TIG, tigecycline. MIC determinations were performed two to three times on independent culture batches. nd, not determined.